s6y Neumora Therapeutics, Inc. EFFECT

Neumora Therapeutics, Inc. EFFECT, filed Mar 26, 2025: primary_doc.xml

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: March 26, 2025
Accession Number: 0001193125-25-044183
Submission Type: POS AM
CIK: 0001885522
Company Name: Neumora Therapeutics, Inc.
File Number: 333-282460